Management of Mycosis Fungoides

Abstract

Cutaneous T cell lymphoma collectively describes non Hodgkin's T cell lymphomas, that have primary cutaneous involvment. Mycosis fungoides and its clinical variant, Sezary syndrome, constitute major subset of CTCL. There are multiple therapeutic <?Ption for MF and SS. Selection of a specific treatment plan is based on the clinical stage of the disease, the assessement of prognositc factors, the accessibility of different treatment approaches, the patient age, and other social, and medical problems and the cost - benefit ratio. The most important factor in designing a treatment plan is the clinical stage of the patient. The goal of treatment of advanced MF is palliation. 0 Survival should be prolonged with an improved quality of life, yet with mininal toxic side effec.ts from therapy.